Lodo Therapeutics
is a New York-based biotechnology firm that discovers and develops novel therapeutics for the treatment of patients with cancer... Read moreLodo Therapeutics
is a New York-based biotechnology firm that discovers and develops novel therapeutics for the treatment of patients with cancer... Read more
News
May 28, 2021
BioSpace
Lodo: Accelerator Life Science Partners' Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.
Oct 27, 2020
BioSpace
Lodo Therapeutics: Lodo Therapeutics Achieves Second Preclinical Milestone In Its Strategic Collaboration With Genentech
Sep 03, 2020
The Pharma Letter
Lodo Therapeutics: Lodo Therapeutics acquires Hibiskus BioPharma
Aug 07, 2020
BioSpace
Lodo Therapeutics: Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Jul 01, 2020
Newyork Citybizlist
Lodo Therapeutics: Lodo Therapeutics Strengthens R&D Leadership
Apr 07, 2020
BioSpace
Lodo Therapeutics: Lodo Therapeutics Achieves Preclinical Milestone In Strategic Collaboration with Genentech
Aug 15, 2018
Pharamceutical Technology
Lodo Therapeutics: Big soil: Genentech and Lodo launch $1bn project to develop new drugs from earth
May 10, 2018
PharmaLeaders
Lodo Therapeutics: Genentech, Lodo Therapeutics form $969m drug discovery collaboration
May 09, 2018
BioCentury
Lodo Therapeutics: Lodo, Genentech partner on R&D for microbial-derived therapies
Dec 24, 2015
www.sec.gov
Lodo Therapeutics: Received $3.5M in Equity Funding
Lodo Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10